Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Tony and Christine Callaghan, who were both injured in the attack, said they were angered to learn of the slow response by security forces.
Police offer £50,000 reward for information on a fire in Chinatown that killed homeless men.
The Government plans to bring forward legislation to ensure all children from age four learn about safe and healthy relationships.